Literature DB >> 24057876

Co-localization of serine/threonine kinase 33 (Stk33) and vimentin in the hypothalamus.

Bastienne Brauksiepe1, Lisa Baumgarten, Stefan Reuss, Erwin R Schmidt.   

Abstract

We investigate the immunoreactivity of serine/threonine kinase 33 (Stk33) and of vimentin in the brain of mouse, rat and hamster. Using a Stk33-specific polyclonal antibody, we show by immunofluorescence staining that Stk33 is present in a variety of brain regions. We found a strong staining in the ependymal lining of all cerebral ventricles and the central canal of the spinal cord as well as in hypothalamic tanycytes. Stk33 immunoreactivity was also found in circumventricular organs such as the area postrema, subfornical organ and pituitary and pineal glands. Double-immunostaining experiments with antibodies against Stk33 and vimentin showed a striking colocalization of Stk33 and vimentin. As shown previously, Stk33 phosphorylates recombinant vimentin in vitro. Co-immunoprecipitation experiments and co-sedimentation assays indicate that Stk33 and vimentin are associated in vivo and that this association does not depend on further interacting partners (Brauksiepe et al. in BMC Biochem 9:25, 2008). This indicates that Stk33 is involved in the dynamics of vimentin polymerization/depolymerization. Since in tanycytes the vimentin expression is regulated by the photoperiod (Kameda et al. in Cell Tissue Res 314:251-262, 2003), we determine whether this also holds true for Stk33. We study hypothalamic sections from adult Djungarian hamsters (Phodopus sungorus) held under either long photoperiods (L:D 16:8 h) or short photoperiods (L:D 8:16 h) for 2 months. In addition, we examine whether age-dependent changes in Stk33 protein content exist. Our results show that Stk33 in tanycytes is regulated by the photoperiod as is the case for vimentin. Stk33 may participate in photoperiodic regulation of the endocrine system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24057876     DOI: 10.1007/s00441-013-1721-8

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  6 in total

1.  The serine/threonine kinase 33 is present and expressed in palaeognath birds but has become a unitary pseudogene in neognaths about 100 million years ago.

Authors:  Tobias Lautwein; Steffen Lerch; Daniel Schäfer; Erwin R Schmidt
Journal:  BMC Genomics       Date:  2015-07-22       Impact factor: 3.969

2.  Correlation between STK33 and the pathology and prognosis of lung cancer.

Authors:  Yi Lu; Jie Tang; Wenmei Zhang; Ce Shen; Ling Xu; Danrong Yang
Journal:  Oncol Lett       Date:  2017-08-17       Impact factor: 2.967

3.  Gene-level genome-wide association analysis of suicide attempt, a preliminary study in a psychiatric Mexican population.

Authors:  Thelma Beatriz González-Castro; José Jaime Martínez-Magaña; Carlos Alfonso Tovilla-Zárate; Isela Esther Juárez-Rojop; Emmanuel Sarmiento; Alma Delia Genis-Mendoza; Humberto Nicolini
Journal:  Mol Genet Genomic Med       Date:  2019-10-02       Impact factor: 2.183

4.  Rax-CreERT2 knock-in mice: a tool for selective and conditional gene deletion in progenitor cells and radial glia of the retina and hypothalamus.

Authors:  Thomas Pak; Sooyeon Yoo; Ana L Miranda-Angulo; Ana M Miranda-Angulo; Hong Wang; Seth Blackshaw
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

5.  Functional interleukin-6 receptor-α is located in tanycytes at the base of the third ventricle.

Authors:  F Anesten; C Santos; E Gidestrand; E Schéle; V Pálsdóttir; T Swedung-Wettervik; B Meister; K Patrycja Skibicka; J-O Jansson
Journal:  J Neuroendocrinol       Date:  2017-12       Impact factor: 3.627

6.  STK33 alleviates gentamicin-induced ototoxicity in cochlear hair cells and House Ear Institute-Organ of Corti 1 cells.

Authors:  Meijuan Zhou; Gaoying Sun; Lili Zhang; Guodong Zhang; Qianqian Yang; Haiyan Yin; Hongrui Li; Wenwen Liu; Xiaohui Bai; Jianfeng Li; Haibo Wang
Journal:  J Cell Mol Med       Date:  2018-09-06       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.